primary vitreous hyperplasia_Cdkn2a<tm1Sxs>/Cdkn2a<tm1Sxs>

http://metadb.riken.jp/0009621I129SvC57BL6Cdkn2atm1SxsCdkn2atm1SxsCdkn2atm1Sxs

primary vitreous hyperplasia_Cdkn2a<tm1Sxs>/Cdkn2a<tm1Sxs>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cyclin-dependent kinase inhibitor 2A
  http://metadb.riken.jp/db/mgi_rdf/MGI:104738

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cdkn2a<tm1Sxs>/Cdkn2a<tm1Sxs>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cdkn2a<tm1Sxs>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129/Sv * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• primary vitreous hyperplasia
  http://purl.obolibrary.org/obo/MP_0009621

文献

http://purl.org/net/cito/citesAsAuthority

• Natalie E. Freeman-Anderson, et.al., Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development., Development (Cambridge, England), 2009, 136
  http://rdf.ncbi.nlm.nih.gov/pubmed/19465598